Neural mechanisms of motion sickness

Journal of Medical Investigation

Volumn 48, Issue 1-2, 2001, Pages 44-59

  Takeda, N ^a   Morita, M ^a   Horii, A ^a   Nishiike, S ^a   Kitahara, T ^a   Uno, A ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Acetylcholine; Amphetamine; Antihismamine; Histamine; Motion sickness; Noradrenaline; Scopolamine; Space motion sickness

Indexed keywords

ACETYLCHOLINE; AMPHETAMINE; ANTIHISTAMINIC AGENT; DIFENIDOL; DOPAMINE 2 RECEPTOR; HISTAMINE; HISTAMINE H1 RECEPTOR; NORADRENALIN; SCOPOLAMINE;

BRAIN DEPTH STIMULATION; CLINICAL FEATURE; DRUG EFFICACY; DRUG MECHANISM; HABITUATION; HUMAN; MOTION SICKNESS; NEUROTRANSMITTER RELEASE; NONHUMAN; PATHOPHYSIOLOGY; RECEPTOR INTRINSIC ACTIVITY; REVIEW;

ANIMALS; DISEASE SUSCEPTIBILITY; HUMANS; MOTION SICKNESS; NEURONS; SIGNAL TRANSDUCTION;

EMESIS;

EID: 0035066802     PISSN: 13431420     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (100)

1. Motion sickness
2. Role of the vestibular end organs in experimental motion sickness: A primate model
3. Space motion sickness
4. Space motion sickness monitoring experiment: Spacelab 1
5. Motion sickness adaptation: A neural mismatch model
6. Motion sickness
7. Motion sickness: A synthesis and evaliatione of the sensory conflict theory
8. Orientation perception, motion sickness and vertigo: Beyond the sensory conflict approach
9. Drugs used in motion sickness
10. A theory of motion sickness based on pharmacological reactions
11. Human assay of anti-motion sickness drugs
12. Lack of effects of astemizole on vestibular ocular reflex, motion sickness and cognitive performance in man
13. Histaminergic mechanisms of motion sickness: Neurochemical and neuropharmacological studies in rats
14. Pica as an index of motion sickness in rats
15. Pica in rats is analogous to emesis: An animal model in emesis research
16. Effects of anti-motion sickness drugs on motion sickness in rats
17. Neurochemical mechanisms of motion sickness
18. Pharmacology of α-fluoromethylhistidine, a specific inhibitor of histidine decarboxylase
19. α-fluoromethylhistidine but not diphenhydramine prevents motion-induced emesis in the cat
20. Role of histamine in motion sickness in Suncus Murinus
21. Histaminergic projection from the posterior hypothalamus to the medial vestibular neucleus of rats and its relation to motion sickness
22. Distribution of histaminergic neurons and fibers in rat brain
23. Effect of unilateral vestibular stimulation on histamine release from the hypothalamus of rats in vivo
24. A ground-based animal model of space adaptation syndrome
25. Histamine release from the hypothalamus induced by gravity change in rats and space motion sickness
26. Neuropharmacology of motion sickness and emesis
27. Organization of histaminergic fibers in the rat brain
28. Observations on the connectivity of the parvicelluar recticular formation with respect to a vomiting center
29. 1-receptors in the rat brain: An autoradiographic study
30. Behavioral effects of intracerebroventricular injection of histamine in dogs
31. Vomiting and anti-emetic drugs
32. Increased secretion of growth hormone, prolactin, antidiuretic hormone and cortisol induced by the stress of motion sickness
33. An analysis of histaminergic efferents of the tuberomamillary nucleus to the medial preoptic area and inferior colliculus of the rat
34. Neurotransmitter regulation of anterior pituitary hormones
35. Effects of anti-cholinergic and cholinergic drugs on habituation to motion in rats
36. Transdermal delivery of scopolamine for prevention of motion sickness at sea
37. The Repubric of Singapore Navy's scopolamine TTS study: Results after 2.200 man-day at sea
38. The effect of antimotion sickness drugs on habituation to motin
39. Atropine, scopolamine and related antimuscarinic drugs
40. The central cholinergic system studied by choline acetyltransferase immunohistochemistry in the cat
41. The organization and some projections of cholinergic neurons of the mammalian forebrain
42. Spatial learing and memory processes: The search for their neurobiological mechanisms in the rat
43. A computational theory of the hippocampal cognitive map
44. Release of acetypcholine from the hippocampus of freely moving rats during sensory stimulation and running
45. Effect of vestibular stimulation on acetylcholine release from rat hippocampus: An in vivo microdialysis study
46. Cholinergic mechanisms, adaptive brain processes and psychopathology
47. Sensory conflict theory of space motion sickness: An anatomical location for the neuroconflict
48. Motion sickness: A modulatory role for the central cholinergic nervous system
49. Neurophysiology of motion sickness
50. Spatial learing and memory processes: The search for their neurobiological mechanisms in the rat
51. Search and attention: Interactions of the hippocampal-septal axis, adrenocortical and gonadal hormones
52. Hippocampal place units in the freely moving rat: Why they fire where they fire
53. A computational theory of the hippocampal cognitive map
54. Cholinergic mechanisms in learning, memory and dementia: A review of recent evidence
55. Cholinergic modulation of cortical associative memory function
56. Acetylcholine and memory
57. The ascending cholinergic reticular system: Neocortical, olfactory and subcortical projections
58. Afferent to the ventral tegmental nucleus of Gudden in the mouse, rat and cat
59. Origin of neural inputs to the region of the tuberomammillary nucleus of the rat brain
60. Vestibular modulation of the septo-hippocampal cholinetgic system of rats
61. Secondary vestibular cholinergic projection to the cerebellum of rabbit and rat as revealed by choline acetyltransferase immunohistochemistry, retrograde and orthograde tracers
62. Topographical distribution of muscarinic cholinergic receptors in the cerebellar cortex of the mouse, rat, guinea pig and rabbit: A species comparison
63. Experimental motion sickness in dogs: Importance of labyrinth and vestibular cerebellum
64. Vestibular-induced vomiting after vestibulocerebellar lesions
65. Effects of vestibular cerebellum lesion on motion sickness in rats
66. Amphetamine and brain catecholamine
67. Catecholaminergic responses to rotational stress in rat brain stem: Implications for amphetamine therapy of motion sickness
68. Central catecholaminergic neuron system: Anatomy and physiology of norepinephrine and epinephrine systems
69. Locus coeruleus-induced inhibition of dorsal cochlear nuckeus neurons in comparison with lateral vestibular neurons
70. GABAergic inhibitory response of locus coeruleus neurons to caloric vestibular stimulation in rats
71. Responses of locus coeruleus and subcoeruleus neurons to sinusoidal stimulation of labyrinthine receptors
72. The brain nucleus locus coeruleus: Restricted afferent control of a broad efferent network
73. GABA-mediated inhibition of locus coeruleus from the dorsomedial rostral media
74. Effects of caloric vestibular stimulation on prepositus hypoglossi neurons in rats
75. Neurons in rostral ventral medulla mediate vestibular inhibition of locus coeruleus in rats
76. Sopite syndrome: A sometimes sole manifestation of motion sickness
77. Electrophysiological evidence for the involvement of the locus coeruleus in alerting, orienting and attending
78. Arousal and stability: The effects of five new synpathomimetic drugs suggest a new principle for the prevention of space motion sickness
79. Noradrenergic-containing locus coeruleus neurons in behaving rats exhibit pronounced response to non-noxious environmental stimuli
80. Mechanisms of selective attention and space motion sickness
81. Motion sickness: An evolutional hypothesis
82. Area postrema: Chemoreceptor circumventricular organs of the medulla oblongata
83. Failure of metoclopriamde to control emesis or nausea due to tressful angular or linear acceleration
84. Neuropharmacological mechanisms of emesis I. Effects of anti-emetic drugs on motion-and apomorphine-induced pica in rats
85. Motion sickness
86. Vestibular, central and gastral triggering of emesis: A study on individual susceptibility in rats
87. The effect of a susceptibility to motion sickness on the side effects of cancer chemotherapy
88. Neuropharmacological mechanisms of emesis II. Effects of anti-emetic drugs on cisplatin-induced pica in rats
89. Diphenidol for levodopa induced nausea and vomiting
90. Diphenidol for chemotherapy-induced nausea and vomiting
91. 8-OH-DPAT suppresses vomiting in the cat elicited by motion, cisplatin or xylazine
92. Neuropharmacology of emesis induced by anti-cancer therapy
93. The effect on motion sickness and oculomotor function of GR 38032F, a 5HT3-receptor antagonist with anti-emetic properties
94. Transdermal hyoscine (scopolamine): A preliminary review of its pharmacodynamic properties and therapeutic efficacy
95. Adaptation to nauseogenic motion stimuli and its application in the treatment of air sickness
96. Postural behavior and motion sickness
97. Therapeutic effects of antimotion sickness medications on the secondary symptoms of motion sickness